Adverse events of fluoxetine: postmarketing compared with premarketing clinical trials.
Musa
M N
MN
Staneluis
J M
JM
D016009:Chi-Square Distribution; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004346:Drug Information Services / Q000706:statistics & numerical data; D005473:Fluoxetine / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011358:Product Surveillance, Postmarketing / Q000706:statistics & numerical data; D012014:Reference Books, Medical; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*; D020018:Sexual Dysfunctions, Psychological / Q000139:chemically induced / Q000453:epidemiology
D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors